Product Information
TAZAROTENE 0.1% GEL is a generic product labeled by Solaris Pharma Corporation, priced at $6.5176 per GM under NDC 73473031030. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Mar 20, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/g
Manufacturer
Solaris Pharma CorporationNDC
73473031030
Classification
Generic
Dosage Form
GEL
Route
CUTANEOUS
Effective Date
8/19/2026
Active Ingredients
TAZAROTENEApproval Type
Generic (ANDA)
FDA Application
ANDA213644FDA Approved
3/20/2023
TE Code
AB
On Market Since
1/3/2025
Pharmacological Classes
Price Statistics
The NADAC for TAZAROTENE 0.1% GEL has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 30.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.5176 per GM |
|---|---|
| All-time high | $9.4818 (Jun 12, 2024) |
| All-time low | $6.5176 (Aug 19, 2026) |
| 52-week high | $8.6762 |
| 52-week low | $6.5176 |
| Median price | $8.3030 |
| Average price | $8.2358 |
| Largest weekly change | -9.7% (Jun 19, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Tazarotene market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TAZAROTENE 0.1% GEL?
The current National Average Drug Acquisition Cost (NADAC) for TAZAROTENE 0.1% GEL, manufactured by Solaris Pharma Corporation, is $6.5176 per GM (NDC 73473031030), effective Aug 19, 2026.
How has the price of TAZAROTENE 0.1% GEL changed over time?
Over the history we have for it, the NADAC for TAZAROTENE 0.1% GEL has declined 30.4%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for TAZAROTENE 0.1% GEL?
Since Apr 17, 2024, the NADAC for TAZAROTENE 0.1% GEL has ranged from a low of $6.5176 (Aug 19, 2026) to a high of $9.4818 (Jun 12, 2024), with a median of $8.3030 per GM.
Are there cheaper alternatives to TAZAROTENE 0.1% GEL?
No other NADAC-published product currently shares the active ingredient and strength of TAZAROTENE 0.1% GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TAZAROTENE 0.1% GEL?
TAZAROTENE 0.1% GEL (NDC 73473031030) is labeled by Solaris Pharma Corporation, and CMS classifies it as a generic product.